Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 44 results found. Search for [ favipiravir trial ]

Results 1 to 21 of 44
BusinessToday.In
November 23, 2020
The study found that patients of confirmed COVID-19 with moderate symptoms were discharged from hospital earlier than those patients that did not receive Favipiravir, with the median time to clinical cure reduced by 2.5 days compared with the control group.


BusinessToday.In
November 7, 2020
Recently, Indian pharma companies are witnessing rampant cyber threats as they are delivering affordable medicines on a large scale amid the coronavirus pandemic


PB Jayakumar
September 11, 2020
\"It (candidate drug PNB-001) has shown remarkable results in lung inflammation and ARDS (Acute Respiratory Distress Syndrome)\", says PN Balaram, CEO of PNB Vesper


BusinessToday.In
August 6, 2020
Coronavirus treatment: With the 400 mg FabiFlu, patients could undergo a more relaxed dosage. The company said that reducing pill burden has been a demand from doctors and patients alike


PB Jayakumar
August 5, 2020
The vaccine, using the platform of plasmid DNA, was found to be safe and well tolerated in the Phase I, which began on 15 July, said Zydus Cadila


BusinessToday.In
August 4, 2020
FluGuard to be available in market from this week; Sun Pharma to work closely with government and medical community to ensure availability of FluGuard to patients across country


Reuters
July 27, 2020
In April, Moderna had received $483 million from the U.S. federal agency that funds disease-fighting technology, when the experimental vaccine was in an early-stage trial conducted by the U.S. National Institutes of Health


BusinessToday.In
July 24, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates:  The study showed that curcumin can prevent Transmissible gastroenteritis virus (TGEV)- an alpha-group coronavirus that infects pigs, from infecting cells. The higher doses of curcumin were also found to kill virus particles


Reuters
July 24, 2020
Unlike other vaccine deals signed by the government, Pfizer and BioNTech will not collect a payment until their vaccine proves to be safe and effective in a large pivotal clinical trial expected to start this month


BusinessToday.In
July 23, 2020
Stocks to watch today on July 23: Vodafone Idea, Larsen & Turbo, Rallis India, ICICI Securities among others are the top stocks to watch out for in Thursday's trading session.


BusinessToday.In
July 22, 2020
Coronavirus treatment: Patients who were administered Glenmark's FabiFlu saw 40 per cent faster achievement of clinical cure


PB Jayakumar
July 21, 2020
Glenmark says compared to other therapies approved for emergency use in COVID-19 in India, FabiFlu is much more economical and an effective treatment option; DCGI had earlier asked it to clarify on allegation that the drug was unaffordable due to its high pricing


Reuters
July 21, 2020
\"Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,\" the company said in a statement to the exchanges


BusinessToday.In
July 19, 2020
The drug controller DCGI said that Glenmark's Fabiflu has been priced too high and is not in the common interest of poor, lower middle class and middle class people of the country


BusinessToday.In
July 13, 2020
Glenmark has also started a post-marketing surveillance study on FabiFlu in 1,000 patients to assess its efficacy and safety


Reuters
July 10, 2020
Known generically as favipiravir, Avigan was developed by a subsidiary of Fujifilm and it was approved in Japan as an emergency influenza treatment in 2014


E Kumar Sharma
July 1, 2020
Avigan, an antiviral drug to fight influenza, is believed to be effective in treatment of COVID-19 patients


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.


BusinessToday.In
New Delhi, June 25, 2020
Coronavirus vaccine news: Johnson and Johnson has expedited its trials for the COVID vaccine. The final stage of the trial expected to begin in September has been pushed up to the second half of July


PAGES 1 OF 3  123